Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Abingworth LLP Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Carlyle Group Inc. (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Converted 329,930 shares @ $1.75, valued at $577.4k
Converted 1,092,056 options to buy @ $1.75, valued at $1.9M
Converted 762,126 options to buy @ $0.01, valued at $7.6k
08/04/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/10/2023 4 Carlyle Group Inc. (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Bought 1,092,056 options to buy @ $1.75, valued at $1.9M
Bought 1,778,000 options to buy @ $2.5, valued at $4.4M
05/05/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/10/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/11/2022 SC 13D/A Abingworth LLP reports a 4.4% stake in Verona Pharma plc
07/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/13/2022 SC 13G Abingworth LLP reports a 5.5% stake in HILLEVAX, INC.
04/08/2022 SC 13D/A Abingworth LLP reports a 15.3% stake in Soleno Therapeutics Inc.
04/07/2022 SC 13D/A Abingworth LLP reports a 11.1% stake in Vera Therapeutics, Inc.
03/31/2022 4 Abingworth LLP (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Bought 7,720,000 shares @ $0
Granted 20,000 options to buy @ $1.57, valued at $31.4k
Granted 13,000 options to buy @ $2.5, valued at $32.5k
Granted 9,530 options to buy @ $3.41, valued at $32.5k
Granted 40,000 options to buy @ $2.24, valued at $89.6k
Granted 31,862 options to buy @ $1.02, valued at $32.5k
Bought 7,720,000 warrants @ $0.3, valued at $2.3M
03/23/2022 4 Abingworth LLP (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 78,045 options to buy @ $3.54, valued at $276.3k
03/21/2022 SC 13D/A Abingworth LLP reports a 8.9% stake in Sierra Oncology, Inc.
02/25/2022 SC 13D/A Abingworth LLP reports a 6.5% stake in Exicure, Inc.
02/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2022 SC 13G/A Abingworth LLP reports a 7.9% stake in VAXCYTE, INC.
02/10/2022 SC 13D/A Abingworth LLP reports a 11.3% stake in Sierra Oncology, Inc.
02/01/2022 4 Abingworth LLP (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Bought 150,000 shares @ $27, valued at $4.1M
Exercised (in-or-at-the-money) 287,471 options to buy @ $13.2, valued at $3.8M
12/17/2021 4 Abingworth LLP (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $11.36, valued at $454.4k
11/15/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/05/2021 3 Abingworth LLP (10% Owner) has filed a Form 3 on Sierra Oncology, Inc.
11/05/2021 SC 13D/A Abingworth LLP reports a 12.6% stake in Sierra Oncology, Inc.
10/04/2021 SC 13D Abingworth LLP reports a 15.4% stake in Jasper Therapeutics, Inc.
10/01/2021 3 Abingworth LLP (10% Owner) has filed a Form 3 on Jasper Therapeutics, Inc.
09/03/2021 SC 13D Abingworth LLP reports a 11.9% stake in eFFECTOR Therapeutics, Inc.
08/27/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
08/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/24/2021 SC 13D Abingworth LLP reports a 14.6% stake in Vera Therapeutics, Inc.
05/18/2021 4 Abingworth LLP (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Converted 2,187,504 shares @ $0
Bought 772,727 shares @ $11, valued at $8.5M
Granted 9,925 options to buy @ $11, valued at $109.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy